Dario Wins Contract with One of New Jersey's Largest Health Plans Representing 1.5 Million Covered Lives
New Amwell-enabled contract in New Jersey adds access to about 1.5 million covered lives starting in early 2027.
Rhea-AI Summary
DarioHealth (DRIO) signed a new contract with a leading New Jersey health plan representing approximately 1.5 million covered lives, secured via channel partner Amwell.
The agreement covers deployment of Dario's cardiometabolic suite and provider-backed care, which is expected to launch and begin generating revenue in the first quarter of 2027. The customer is an administrative services only health plan, giving Dario access to a large population of self-funded employer groups. This is the third large state health plan Dario has signed through Amwell in the past 12 months, following contracts with major health insurers in Arizona and Florida, and it expands the reach of Dario's multi-condition digital health platform.
Positive
- New NJ health plan contract adds access to ~1.5 million covered lives
- Third large state health plan signed through Amwell in 12 months
- Revenue from this agreement expected to begin in Q1 2027
- ASO plan structure provides access to many self-funded employer groups
Negative
- None.
Key Figures
- Covered lives
- approximately 1.5 million covered lives
- New Jersey health-plan agreement
- Revenue launch timing
- Q1 2027
- Expected agreement launch and revenue generation
- Large health-plan contracts
- 3 contracts
- Secured through Amwell in the past 12 months
Historical Context
-
Reported Amwell channel expansion alongside $13.1 million contracted and late-stage ARR.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
administrative services only financial
covered lives financial
self-funded employer groups financial
cardiometabolic medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Agreement secured through channel partner Amwell significantly expands Dario's reach through its channel distribution strategy
Program for Dario's cardiometabolic suite and provider-backed care expected to launch with the customer and begin generating revenue in the first quarter of 2027
Marks the third large state health plan signed through Amwell in the past 12 months, following contracts in
The new agreement represents a significant expansion of Dario's reach into large health plan populations and further demonstrates the scalability of the Company's channel distribution strategy. As an administrative services only ("ASO") health plan, the customer provides Dario with the opportunity to access a large population of self-funded employer groups that will be able to deploy Dario's cardiometabolic solutions.
"This is exactly the type of scale we envisioned when we built our channel strategy," said Erez Raphael, Chief Executive Officer of Dario. "A single agreement gives Dario the opportunity to reach one and a half million covered lives through one of
The agreement further expands Dario's relationship with Amwell as a scalable distribution channel and stands in addition to previously secured contracts with major health insurers in
Dario's integrated platform enables health plans and employers to address multiple chronic conditions through a single solution spanning diabetes, hypertension, weight management, musculoskeletal and behavioral health needs. Dario has also expanded its platform to include provider-backed clinical care, extending its capabilities from continuous digital engagement and chronic condition management through provider-led care.
About DarioHealth Corp.
DarioHealth (Nasdaq: DRIO) is an AI-powered healthcare technology company helping health plans, health systems and employers improve health outcomes while lowering the cost of care. The Company's integrated platform combines connected devices, personalized member engagement, AI-driven insights and provider-backed clinical care to support people living with conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health needs.
Powered by more than 13 billion proprietary longitudinal healthcare data points collected over more than a decade, Dario's AI platform personalizes care at the individual member level by analyzing biometric, clinical and behavioral data to deliver more timely and effective interventions. By combining engagement, clinical intelligence and care delivery within a single platform, Dario helps customers address multiple chronic conditions through one solution.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and partners of DarioHealth Corp. related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. For example, the Company is using forward-looking statements in this press release when it discusses the expected launch of the program with the New Jersey health plan and the timing thereof; the expectation that the program will begin generating revenue in the first quarter of 2027; the ability of the agreement and the Company's relationship with Amwell to expand the Company's reach to covered lives and self-funded employer groups; the potential deployment of Dario's cardiometabolic solutions by such employer groups; and the scalability, growth potential and expected benefits of the Company's channel distribution strategy, platform and provider-backed care capabilities. Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company's results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company's filings with the U.S. Securities and Exchange Commission. Readers are cautioned that actual results (including, without limitation, the timing for and results of the Company's commercial and regulatory plans for Dario™ as described herein) may differ significantly from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
DarioHealth Corporate Contacts
Michael Lipari
SVP Corporate Development
irteam@dariohealth.com
+1-201-785-6310
Rob Halpern
SVP Marketing
irteam@dariohealth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/dario-wins-contract-with-one-of-new-jerseys-largest-health-plans-representing-1-5-million-covered-lives-302881149.html
SOURCE DarioHealth Corp.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When is the New Jersey health plan program expected to launch and generate revenue for Dario?
The program for Dario's cardiometabolic suite and provider-backed care with the New Jersey health plan is expected to launch and begin generating revenue in the first quarter of 2027.
What type of customer is the New Jersey health plan Dario signed?
The New Jersey customer is an administrative services only (ASO) health plan, which gives Dario the opportunity to access a large population of self-funded employer groups that can deploy Dario's cardiometabolic solutions.
How does this agreement relate to Dario's partnership with Amwell?
The agreement was secured through Dario's strategic channel partnership with Amwell and further expands Amwell's role as a scalable distribution channel for Dario, in addition to existing contracts with major health insurers in Arizona and Florida.
Which chronic conditions can be addressed through Dario's platform for this health plan?
Dario's integrated platform enables health plans and employers to address multiple chronic conditions, including diabetes, hypertension, weight management, musculoskeletal issues and behavioral health needs, through a single solution.